"This study is for patients diagnosed with Primary IgA Nephropathy, a kidney disease . it involves research and is conducted to determine the efficacy and safety of a drug called Nefecon (with the active ingredient, budesonide) The purpose of the study is to look at: • How well Nefecon works for the treatment of kidney disease and more specific for patients with the disease ""primary immunoglobulin A nephropathy"", called IgAN; and • How safe and effective Nefecon is compared to placebo."
Thank you for your interest, but this study is not currently enrolling.
North Carolina (Statewide)
Kidneys and Liver